studies on KPV and alpha-MSHderived regulatory peptide signaling behavior Sikiric, P
Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited
Physiology of Homocysteine1 Homocysteine (Hcy) is made when the body breaks down methionine, an amino acid in protein-rich foods
This combination medicine belongs to a class of nutritional supplements
The phase 1 clinical trials evaluated escalating doses of CB-839 in patients with advanced solid tumors among the patients with triple-negative breast cancer, RCC, mesothelioma, NSCLC, fumarate hydratase (FH)-deficient tumors, succinate dehydrogenase (SDH)-deficient gastrointestinal stromal tumors (GIST) or non-GIST tumors, cMyc-mutated tumors, and isocitrate dehydrogenase-1 (IDH1)- or IDH2-mutant tumors in combination with standard of care chemotherapy
Une diminution des niveaux de cet antioxydant peut affecter de nombreuses fonctions de l'organisme, entranant une varit de symptmes